Received Dec 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | JF7DM | — |
Infanrix administered instead of Boostrix to 7-year patient; Infanrix administered instead of Boostrix to 7-year patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old female patient who received DTPa (Infanrix) (batch number JF7DM, expiry date 29-APR-2027) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis. On 11-NOV-2025, the patient received Infanrix. The patient did not receive Boostrix. On 11-NOV-2025, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Infanrix administered instead of Boostrix to 7-year patient) and wrong vaccine administered (Verbatim: Infanrix administered instead of Boostrix to 7-year patient). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-DEC-2025 Licensed practical nurse reported patient in office was inadvertently administered Infanrix instead of Boostrix to 7-year patient.